Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Board Meeting Intimation for Inter Alia, To Consider And Approve The Unaudited Financial Results Of The Company For The Second Quarter And Half Year Ended September 30, 2018

 GLENMARK PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2018 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the Second Quarter and Half Year ended September 30, 2018. Further, as per the "Code of Conduct for Prevention of Insider Trading" and pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 the Company has...
02-11-2018
Bigul

Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Sub: Glenmark launches globally-renowned hair growth formula Nourkrin in Russia With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record.
01-11-2018
Bigul

Glenmark gets USFDA nod for generic Derma-Smoothe Topical Oil

 Glenmark Pharmaceuticals Tuesday said it has received final approval from the US health regulator for generic version of Derma-Smoothe Topical Oil, u
30-10-2018
Bigul

Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Sub: Glenmark Pharmaceuticals receives ANDA approval for Fluocinolone Acetonide Topical Oil, 0.01% (Scalp Oil). With reference to the subject mentioned above, kindly find attached media release which is self-explanatory.
30-10-2018
Bigul

Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Sub: Glenmark Pharmaceuticals receives ANDA approval for Fluocinolone Acetonide Topical Oil, 0.01% (Body Oil). With reference to the subject mentioned above, kindly find attached media release which is self-explanatory.
26-10-2018
Bigul

Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Sub: Data on Glenmark Pharmaceuticals'' GBR 830, a First-in-Class, Investigational, Anti-OX40 Monoclonal Antibody in Development for the Treatment of Moderate-to-Severe Atopic Dermatitis, to be Presented at the Fall Clinical Dermatology Conference. With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record.
19-10-2018
Bigul

Glenmark gets USFDA nod for generic Westcort cream

 Drug firm Glenmark Pharmaceuticals Monday said it has received final nod from the US health regulator for generic Hydrocortisone Valerate cream used
15-10-2018
Bigul

Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Sub: Glenmark Pharmaceuticals receives ANDA approval for Hydrocortisone Valerate Cream USP, 0.2% With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record.
15-10-2018
Bigul

ANNOUNCEMENT OF SETTLEMENT OF THE REPURCHASE IN RESPECT OF THE COMPANY'S U.S.$200,000,000 2.00 PER CENT. RESETTABLE ONWARD STARTING EQUITY-LINKED SECURITIES DUE 2022

 With respect to the above subject, please find enclosed herewith Announcement of Settlement of the Repurchase.
09-10-2018
Bigul

Intimation Of Settlement By Glenmark Pharmaceuticals Limited ('Company') Of Buyback Of U.S.$86.5 Million ('Buyback Fccbs') Of Its U.S.$200 Million 2 Per Cent Resettable Onward Starting Equity Linked Securities Due 28 June 2022 ('FCC Bonds')

 This is further to our letters dated 1 October 2018 and 3 October 2018, regarding buyback in respect of the FCC Bonds issued in 2016, which are currently listed on the Singapore Exchange Securities Trading Limited. The Company wishes to announce that the buyback of the Buyback FCCBs was completed on 5 October 2018 and the registrar and transfer agent has cancelled the Buyback FCCBs. Accordingly, the aggregate principal amount of FCC Bonds...
09-10-2018
Next Page
Close

Let's Open Free Demat Account